Modus Therapeutics resolves directed share issue at SEK 0.38
Modus Therapeutics’ board resolved a directed new issue of 20,000,000 shares at a subscription price of SEK 0.38, pursuant to AGM authorisation from 28 May 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.